Carl D. Regillo, MD, FACS, FASRS, discusses geographic atrophy, the advanced stage of dry age-related macular degeneration, including its diagnosis, and progression.
Investigators highlight the risk of misdiagnosing geographic atrophy
Spotlighting telemedicine in the year of a pandemic
EMA provides positive ATMP opinion for gene therapy products OCU410 and OCU410ST
CDR-Life completes fifth milestone and is recruiting patients for Phase 2 study of BI 771716
Cognition Therapeutics announces manuscript publication on oral drug candidate zervimesine (CT1812) for treatment of dry AMD
Ocugen, Inc. completes dosing in Phase 2 portion of ArMaDa clinical trial for OCU410